Goldman Sachs Group Inc Portage Biotech Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024
BUY
$5.16 - $11.95 $58,318 - $135,058
11,302 New
11,302 $79,000
Q2 2022

Aug 15, 2022
BUY
$5.16 - $11.95 $58,318 - $135,058
11,302 New
11,302 $79,000

Others Institutions Holding PRTG

# of Institutions
3
Shares Held
28.4K
Call Options Held
0
Put Options Held
0
View Full List

About PORTAGE BIOTECH INC.

PRTG Quotes by TradingView
  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $73M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email